6.67
Schlusskurs vom Vortag:
$6.42
Offen:
$6.8
24-Stunden-Volumen:
34,069
Relative Volume:
0.37
Marktkapitalisierung:
$72.22M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.00189
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
+37.53%
1M Leistung:
+39.25%
6M Leistung:
-12.01%
1J Leistung:
-45.86%
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Firmenname
Avalo Therapeutics Inc
Sektor
Branche
Telefon
410-522-8707
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Vergleichen Sie AVTX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AVTX
Avalo Therapeutics Inc
|
6.67 | 69.51M | 1.93M | -7.96M | -36.78M | -3,530.82 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
2025-03-25 | Eingeleitet | Jefferies | Buy |
2025-03-25 | Eingeleitet | Stifel | Buy |
2025-02-28 | Eingeleitet | Piper Sandler | Overweight |
2025-02-21 | Eingeleitet | Wedbush | Outperform |
2024-12-19 | Eingeleitet | BTIG Research | Buy |
2024-10-24 | Eingeleitet | H.C. Wainwright | Neutral |
2024-04-16 | Hochstufung | Oppenheimer | Perform → Outperform |
2021-09-24 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten
What analysts say about Avalo Therapeutics Inc. stockUnmatched market gains - Autocar Professional
What drives Avalo Therapeutics Inc. stock priceFree Popular Stock Recommendations - jammulinksnews.com
Avalo Therapeutics Inc. Stock Analysis and ForecastBreakthrough stock performance - jammulinksnews.com
Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target - Investing.com Australia
Is Avalo Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional
Avalo Therapeutics Soars 10.66% on Bullish Sentiment - AInvest
Avalo Therapeutics (AVTX) Soars 10.42% on Analyst Upgrade - AInvest
What makes Avalo Therapeutics Inc. stock attractive to long term investorsBalanced Risk Reward Portfolio - Newser
Does Avalo Therapeutics Inc. stock pay reliable dividendsReal Time Alert Service - Newser
What institutions are buying Avalo Therapeutics Inc. stock nowGrowth Optimized Stock Radar - beatles.ru
What makes Avalo Therapeutics Inc. stock price move sharplyBreakout Confirmation Tool - Newser
Why Avalo Therapeutics Inc. stock attracts strong analyst attentionIntraday Trade Ideas - Newser
How Avalo Therapeutics Inc. stock performs during market volatilityVolume Spike Monitors - Newser
(AVTX) Investment Analysis and Advice - news.stocktradersdaily.com
Avalo Adds Dr. Rita Jain to Board as LOTUS Trial Advances - MSN
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
How To Trade (AVTX) - news.stocktradersdaily.com
15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey
Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Avalo Therapeutics Highlights Potential of AVTX-009 in HS - TipRanks
(AVTX) Long Term Investment Analysis - news.stocktradersdaily.com
Avalo Therapeutics appoints Dr. Rita Jain to board of directors By Investing.com - Investing.com Nigeria
Avalo Therapeutics (AVTX) Welcomes New Board Member | AVTX Stock News - GuruFocus
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors - GlobeNewswire
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to B - GuruFocus
Avalo Therapeutics appoints Dr. Rita Jain to board of directors - Investing.com
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Down 45.8% in May - Defense World
AVTX Virtual Meeting Scheduled for June 23 by BTIG | AVTX Stock News - GuruFocus
Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) PT at $30.00 - Defense World
Avalo Therapeutics Signs New Sales Agreement - TipRanks
Avalo Therapeutics Highlights AVTX-009 Potential in HS Market - TipRanks
Northern Trust Corp Invests $168,000 in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World
Avalo Therapeutics (NASDAQ:AVTX) Upgraded at HC Wainwright - Defense World
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):